Stocks and Investing Stocks and Investing
Thu, August 10, 2023

Brian Cheng Upgraded (ADCT) to Hold on, Aug 10th, 2023


Published on 2024-10-28 05:46:35 - WOPRAI, Brian Cheng
  Print publication without navigation


Brian Cheng of JP Morgan, Upgraded "ADC Therapeutics SA" (ADCT) to Hold on, Aug 10th, 2023.

Brian has made no other calls on ADCT in the last 4 months.



There are 4 other peers that have a rating on ADCT. Out of the 4 peers that are also analyzing ADCT, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Reiterated at Hold and Held Target at $5 on, Tuesday, July 11th, 2023


These are the ratings of the 3 analyists that currently disagree with Brian


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $9 on, Wednesday, August 9th, 2023
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Tuesday, July 25th, 2023
  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $2 on, Monday, April 24th, 2023

Contributing Sources